Orthofix Ebit Per Revenue from 2010 to 2025

OFIX Stock  USD 16.51  0.23  1.37%   
Orthofix Medical Ebit Per Revenue yearly trend continues to be fairly stable with very little volatility. Ebit Per Revenue is likely to outpace its year average in 2025. During the period from 2010 to 2025, Orthofix Medical Ebit Per Revenue regression line of annual values had r-squared of  0.63 and arithmetic mean of  0.03. View All Fundamentals
 
Ebit Per Revenue  
First Reported
2010-12-31
Previous Quarter
(0.11)
Current Value
(0.10)
Quarterly Volatility
0.11450215
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Orthofix Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orthofix Medical's main balance sheet or income statement drivers, such as Interest Expense of 31.1 M, Total Revenue of 839.5 M or Gross Profit of 573.2 M, as well as many indicators such as Price To Sales Ratio of 0.79, Dividend Yield of 0.0 or PTB Ratio of 2.38. Orthofix financial statements analysis is a perfect complement when working with Orthofix Medical Valuation or Volatility modules.
  
Check out the analysis of Orthofix Medical Correlation against competitors.
For more information on how to buy Orthofix Stock please use our How to Invest in Orthofix Medical guide.

Latest Orthofix Medical's Ebit Per Revenue Growth Pattern

Below is the plot of the Ebit Per Revenue of Orthofix Medical over the last few years. It is Orthofix Medical's Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Orthofix Medical's overall financial position and show how it may be relating to other accounts over time.
Ebit Per Revenue10 Years Trend
Slightly volatile
   Ebit Per Revenue   
       Timeline  

Orthofix Ebit Per Revenue Regression Statistics

Arithmetic Mean0.03
Geometric Mean0.05
Coefficient Of Variation438.26
Mean Deviation0.08
Median0.04
Standard Deviation0.11
Sample Variance0.01
Range0.4827
R-Value(0.80)
Mean Square Error0.01
R-Squared0.63
Significance0.0002
Slope(0.02)
Total Sum of Squares0.20

Orthofix Ebit Per Revenue History

2025 -0.1
2024 -0.11
2023 -0.19
2022 -0.0449
2021 -0.0134
2020 0.003975
2019 0.0542

About Orthofix Medical Financial Statements

Orthofix Medical investors use historical fundamental indicators, such as Orthofix Medical's Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Orthofix Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Ebit Per Revenue(0.11)(0.10)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Orthofix Stock Analysis

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.